跳至主要内容
临床试验/IRCT20230913059428N1
IRCT20230913059428N1尚未招募3 期

A clinical trial of sublingual Rizatriptan versus oral Betahistin in acute phase treatment of vertigo in patients suffering from vestibular migraine

Tabriz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Including the International Headache Society criteria for vestibular migraine
  • Acute vertigo with moderate to severe intensity

排除标准

  • Patients with suspected vestibular disorders other than vestibular migraine
  • Patients with a suspected history of Orthostatic Hypotension or panic disorders
  • history of basilar or hemiplegic migraine
  • Presence of severe kidney or liver disorders
  • Symptoms suggestive of ischemic heart disease
  • history of HTN
  • history of previous TIA/stoke
  • history of drug or substance or alcohol abuse
  • Systolic blood pressure above 160 or diastolic blood pressure above 90

研究者

相似试验